Get the latest insights on issues impacting mergers and acquisitions from RBC Capital Markets' investment banking team.
Perspectives from the cutting edge of biotech and pharma
Our serialized podcast series delivers highly differentiated insights and intelligence, turning today’s faster-moving trends into tomorrow’s opportunities
Fresh perspective and nuanced, data driven view of the forces shaping U.S. equity markets
Macro and market strategy series – explores the latest financial market and economic developments
Search all podcasts:
Markets in Motion
March 2024
Three big things you need to know: First, one of our key sentiment indicators has started to retreat after hitting...
Industries in Motion
Themes in M&A and Capital Allocation Amongst Global Energy Producers
Pathfinders in Biopharma
U.S. healthcare desperately needs to cut costs and improve outcomes. There is no single solution, but three disruptive...
The biotech industry is poised for an innovation-led rebound, but drug pricing is already in the election crosshairs....
February 2024
Unpack critical considerations across key disruptive areas biopharma industry stakeholders are paying attention to in...
RBC’s Markets in Motion is the weekly podcast from Lori Calvasina, Head of US Equity Strategy at RBC Capital Markets...
In this episode, Maurice Choy (Canadian Energy Infrastructure Analyst), Andrew Wong (Uranium & Fertilizers Analyst)...
4Q23 reporting season stats are similar to what we’ve described in recent weeks, our review of last week’s S&P 500...
Three big things you need to know: First, with reporting season almost halfway done, bottom-up consensus expectations...
Get the latest insights from RBC Capital Markets delivered to your inbox.